Cargando…

CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer

BACKGROUND: CD38 has been observed expressing in activated T cells, while the features and functions of CD38+ T cells in human NSCLC are still unclear. METHODS: Here we uncovered the correlation between CD38 expression and survival and immune infiltration levels in tumor of NSCLC. Then, we collected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Pin, Zhao, Lufeng, Chen, Yongyuan, Xin, Zhongwei, Lin, Mingjie, Hao, Zhixing, Chen, Xiaoke, Chen, Di, Wu, Dang, Chai, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571140/ https://www.ncbi.nlm.nih.gov/pubmed/33934206 http://dx.doi.org/10.1007/s00262-021-02949-w

Ejemplares similares

Tissue‐resident CD69(+)CXCR6(+) Natural Killer cells with exhausted phenotype accumulate in human non‐small cell lung cancer
por: Chen, Xiaoke, et al.
Publicado: (2022)

CD8(+) T Cells Form the Predominant Subset of NKG2A(+) Cells in Human Lung Cancer
por: Chen, Yongyuan, et al.
Publicado: (2020)

The immune landscape of human thymic epithelial tumors
por: Xin, Zhongwei, et al.
Publicado: (2022)

Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
por: Freeman, Gordon J., et al.
Publicado: (2006)

Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer
por: Hao, Zhixing, et al.
Publicado: (2022)

PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells
por: Viramontes, Karla M., et al.
Publicado: (2022)

Strategies to reinvigorate exhausted CD8(+) T cells in tumor microenvironment
por: Guan, Qianting, et al.
Publicado: (2023)

Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle
por: Oh, Se Jin, et al.
Publicado: (2022)

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
por: Ding, Guoping, et al.
Publicado: (2019)

Harnessing allogeneic CD4(+) T cells to reinvigorate host endogenous antitumor immunity
por: Mochizuki, Kazuhiro
Publicado: (2023)

EPS reinvigorated
Publicado: (1973)

Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation
por: He, Teng, et al.
Publicado: (2022)

Reinvigorating therapeutic cancer vaccines
por: Robles-Oteiza, Camila, et al.
Publicado: (2022)

Alloantigen-activated (AAA) CD4(+) T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice
por: Mochizuki, Kazuhiro, et al.
Publicado: (2021)

Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint Blockade
por: Safaeifard, Fateme, et al.
Publicado: (2022)

Reinvigorating electrochemistry education
por: Kempler, Paul A., et al.
Publicado: (2021)

NMI: a potential biomarker for tumor prognosis and immunotherapy
por: He, Teng, et al.
Publicado: (2022)

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
por: Banchereau, Romain, et al.
Publicado: (2021)

Reinvigorating the Role of Science in Democracy
por: Rosenberg, Andrew A., et al.
Publicado: (2013)

The neoadjuvant paradigm reinvigorated: a review of pre-surgical immunotherapy in HNSCC
por: Stafford, Margaret, et al.
Publicado: (2020)

4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39(+) CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
por: Leem, Galam, et al.
Publicado: (2020)

Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response
por: McGoverne, Isabella, et al.
Publicado: (2020)

Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
por: Wu, Si-Pei, et al.
Publicado: (2015)

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
por: Liu, Huazhen, et al.
Publicado: (2019)

Reinvigorating the public health response to dementia
por: The Lancet Public Health
Publicado: (2021)

Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
por: Escors, David, et al.
Publicado: (2022)

Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies
por: Verkleij, Christie P. M., et al.
Publicado: (2020)

CD19(+)CD24(hi)CD38(hi) B Cell Dysfunction in Primary Biliary Cholangitis
por: Chen, Qubo, et al.
Publicado: (2020)

PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1(hi)CD39(+) CD4 T cells
por: Balança, Camille-Charlotte, et al.
Publicado: (2021)

Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer
por: Zhou, Jian, et al.
Publicado: (2020)

TV doctor reinvigorates child dental campaign
Publicado: (2020)

TV doctor reinvigorates child dental campaign
Publicado: (2020)

How to Sabbatical Successfully (and Reinvigorate Your Career)?
por: Reichardt, Juergen K. V.
Publicado: (2022)

Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
por: Xiong, Dian, et al.
Publicado: (2023)

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127(+) and KLRG1(+) CD8 T cells
por: Hui, Zhenzhen, et al.
Publicado: (2023)

Functional Change of Effector Tumor-Infiltrating CCR5(+)CD38(+)HLA-DR(+)CD8(+) T Cells in Glioma Microenvironment
por: Chen, Pin-Yuan, et al.
Publicado: (2019)

Reinvigorating an Academy of Medical Educators Using Ecological Systems Theory
por: Zwemer, Eric, et al.
Publicado: (2022)

Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer
por: Wang, Yumeng, et al.
Publicado: (2022)

Blockade of PD-1 and LAG-3 expression on CD8+ T cells promotes the tumoricidal effects of CD8+ T cells
por: Ma, Jiajia, et al.
Publicado: (2023)

The Epistemic Imperialism of Science. Reinvigorating Early Critiques of Scientism
por: Mazur, Lucas B.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jnu7e5ubidjgl7llj3lp19bjg4